Multi-omics approaches use a diversity of high-throughput technologies to profile the different molecular layers of living cells. Ideally, the integration of this information should result in comprehensive systems models of cellular physiology and regulation. However, most multiomics projects still include a limited number of molecular assays and there have been very few multi-omic studies that evaluate dynamic processes such as cellular growth, development and adaptation. Hence, we lack formal analysis methods and comprehensive multi-omics datasets that can be leveraged to develop true multi-layered models for dynamic cellular systems. Here we present the STATegra multi-omics dataset that combines measurements from up to 10 different omics technologies applied to the same biological system, namely the well-studied mouse pre-B-cell differentiation. STATegra includes highthroughput measurements of chromatin structure, gene expression, proteomics and metabolomics, and it is complemented with single-cell data. To our knowledge, the STATegra collection is the most diverse multi-omics dataset describing a dynamic biological system.
addition to the exciting technical reality of being able to monitor several complementary datatypes, the community has come to realize the power of using time in the experimental design. Hence, by collecting data over time, where as a rule the different molecular entities are correlated, it is much more amenable to extract key processes from each data-type as well as uncovering dependencies between different regulatory layers. These technical and conceptual advances are currently being transferred into the vibrant single-cell biology community. Thus, recent advances in single-cell omics technologies have made it feasible to perform multi-omics profiling of individual cells. Consequently, the single-cell community can benefit from the experiences and lessons derived from time-dependent bulk multi-omics analysis. Clearly, a high-resolution single-cell analysis has proven crucial to assess tissue heterogeneity [13] [14] [15] , cell fate 16, 17 . In conclusion, we are most likely entering an era where we can target regulatory networks in single cells 18 using a temporal paradigm coupled to a multiomics analysis .
While multi-omics projects are frequently depicted as a set of stacked molecular layers that are connected to pass information from the genetic component to the organismal phenotype, the harsh reality is that still many multi-omics project are constrained by budgetary restrictions and sample limitations which evidently reduce the number technologies that can realistically be assessed. In most cases, only a few data types can be included, with a limited number of samples, and analyses is as a rule restricted to focus on 2 or 3 regulatory layers. A few international projects have however successfully collected large datasets and generated comprehensive portfolios of omics measurements. For example, ENCODE 19 , TCGA 20 , IHE 21 , ImmGen 22 , had the explicit goal to perform an extensive characterisation of a particular set of cells or tissues. These projects have impacted the scope and type of analysis methods and scientific discoveries that can be achieved so far by the multiomic approach. In some cases combining multi-level data has the ambition to increase the required statistical power to enable the classification of samples or predict disease outcomes. By measuring different types of features. the chance of identifying relevant biomarkers increases, but the analysis does not automatically lend itself to an mechanistic account of the inter-dependencies between these biomarkers as well as their relationship with the outcome, such as a disease. In some cases however, two specific omics layers are measured in order to probe their regulatory relationships. For example, methods that integrate ATAC-seq or RRBS with RNA-seq might shed light on the epigenetic control of gene expression 23 , while integrating transcriptomics and metabolomics data may help elucidate metabolic regulation 24, 25 . Yet, there have been very few multi-omic studies that evaluate dynamic processes such as cellular growth, development and adaptation.
Hence, we still lack formal analysis methods and comprehensive multi-omics datasets that can be leveraged to develop true multi-layered models for dynamic cellular systems. This state-of-affairs has been the rationale underpinning the formulation of what is referred to as the STATegra project (http://www.stategra.eu/). This is a transnational initiative to develop methods, software and data for dynamic multi-omics analyses. From the STATegra several tools for integrative multiomics data analyses have been published and released [26] [27] [28] [29] [30] [31] [32] .
Here we share the collection of the different STATegra data-sets, a multi-omics dataset that combines measurements from up to 10 different omics technologies applied to the same biological system. STATegra covers the three types of biomolecules and the different layers that comprise the basic flow of genetic information: chromatin structure (through DNase-seq, RRBS and ChIP-seq), gene expression (RNA-seq and miRNA-seq), proteomics and metabolomics. The collection is complemented with single-cell RNA-seq and ATAC-seq data. STATegra uses a well studied system, namely mouse pre-B-cell differentiation, in a cell line model. This is a highly reproducible in vitro system that allows the generation of sufficient material to deploy a comprehensive set of omics measurements. The STATegra multi-omics dataset is unique in the number and diversity of omics technologies available and in the dynamic nature of the system. Our ambition has been to generate this collection of data to serve as gold standard for the development of integrative analysis methods for the multi-layered systems biology.
ChIP-seq data have been used in 33 to identify Ikaros targets. ChIP-seq, DNase-seq, RNAseq and scRNA-seq datasets were used in 34 to describe the cross-talk between IKAROS Foxo1 and Myc transcription factors in regulating B-cell development. Figure 1 illustrates the STATegra dataset. The mouse B3 cell line models the pre-BI (or Hardy fraction C') stage. Upon nuclear translocation of the Ikaros transcription factor these cells progress to the pre-BII (or Hardy fraction D) stage, where B cell progenitors undergo growth arrest and differentiation 33, 35 . The B3 cell line was retrovirally transduced with a vector encoding an Ikaros-REt2 fusion protein, which allows control of nuclear levels of Ikaros upon exposure to the drug Tamoxifen 33 . In parallel, cells were transfected with an empty vector to serve as control for the Tamoxifen effect. After drug treatment, cultures were harvested at 0h, 2h, 6h, 12h, 18h and 24hs ( Figure 1A ) and profiled by several omics technologies: long messenger RNA-seq (mRNA-seq) and small messenger RNA-seq (miRNA-seq) to measure gene expression; reduced representation by bisulfite sequencing (RRBS) to measure DNA methylation; DNase-seq to measure chromatin accessibility as DNaseI Hypersensitive Sites (DHS) and transcription factor footprints, shotgun proteomics and targeted metabolomics of primary carbon and amino-acid metabolism. Moreover, single cell RNA-seq (scRNA-seq) data for the entire time-series, while bulk ATAC-seq (ATAC-seq) and single-cell ATAC-seq (scATAC-seq) were obtained for 0h and 24h-time points of Ikaros induction only (no control series were run for these datasets). The dataset is complemented by existing ChIP-seq data on the same system equivalent to our 0h and 24h time points 33 . In total, 793 different samples across the different omics datasets define the STATegra data collection ( Figure 1B ). 
Methods

Experimental design
Culture conditions
4-OHT
Ikzf1-Ert2
Control-Ert2 obtain 50M reads per library, therefore 100M reads per sample. Libraries were built using the strand-specific RNA-seq dUTP protocol 36 . Sequencing was conducted on an Illumina
HiSeq 2500 platform. 
miRNA-seq
Small RNA-seq analysis was performed using Trizol-extracted total RNA of 3 biological repicates (4,5,6) for time 0h and total RNA of 3 biological batches (1, 2 and 3) for times 2h, 6h, 12h, 18h and 24h. RNA quality was assessed using Bioanalyzer (Agilent Technologies) evaluating the RNA integrity number (RIN). The library was generated using TruSeq Small The library preparation and sequencing of the biological replicates were conducted in two different occasions (technical batches). Figure 3 shows the experimental design according to the batch in which samples were processed. There were two experimental conditions (C=Control, IK=Ikaros) and the 3 biological replicates per condition and time point were numbered as 1, 2 and 3. For some of these biological replicates, also technical replicates were generated in order to estimate the variability between technical batches and to correct any potential batch effect. were further sequenced and merged to achieve a minimum of 200 million mapped reads.
RRBS
Genomic DNA was isolated using the high salt method and used for reduced representation bisulfite sequencing (RRBS), a bisulfite-based protocol that enriches CG-rich parts of the genome, thereby reducing the amount of sequencing required while capturing the majority of promoters and other relevant genomic regions. This approach provides both singlenucleotide resolution and quantitative DNA methylation measurements. In brief, genomic C1   C2   C3   IK1   IK2   IK3   C1   C2   C3   IK1  IK1  IK1  IK1  IK1   IK2  IK2  IK2  IK2  IK2   IK3  IK3  IK3  IK3  IK3   C1   C2   C1  C1  C1  C1   C2  C2  C2  C2  C2   C3  C3  C3  C3  C3   IK1  IK3  IK2  IK1  Second Sequencing Batch   0h  2h  6h  12h  18h  24h DNA is digested using the methylation-insensitive restriction enzyme MspI in order to generate short fragments that contain CpG dinucleotides at the ends. After end-repair, Atailing and ligation to methylated Illumina adapters, the CpG-rich DNA fragments bp) are size selected, subjected to bisulfite conversion, PCR amplified and then sequenced on an Illumina HiSeq2500 PE 2x100bp 37 . The libraries were prepared for 100-bp paired-end sequencing. Around 30 millions of sequencing reads were obtained from each sample.
First Sequencing Batch
Single cell RNA-seq
Single cells were isolated using the Fluidigm C1 System. Single cell C1 runs were completed 
Bulk and single cell ATAC-seq
Single-cell ATAC-seq was performed using the Fluidigm C1 system as done previously 38 .
Briefly, cells were collected for 0 and 24-hours post treatment with tamoxifen, at a concentration of 500 cells/µl in a total of 30-50 µl. Additionally, 3 biological replicates of ~50,000 cells were collected for each measured time-point to generate bulk ATAC-seq measurements. Bulk ATAC-seq was performed as previously described 3 . ATAC-seq peak calling was performed using bulk ATAC-seq samples. ATAC-seq peaks were then used to estimate single-cell ATAC-seq signal. Our C1 single-cell capture efficiency was ~70-80% for 
Omics pre-processing
Data pre-processing is next described in detail for each omics type. Figure 4 shows an comparative overview of the different preprocessing pipelines. 
RNA-seq
Tophat2 39 was used to map fragments to the mm10 reference genome; the very-sensitive mode only allowing a unique best mapping per fragment was used. Piccard (https://broadinstitute.github.io/picard/) and Fastqc 40 were used to perform a quality control considering elements such as duplication levels, GC content and k-mer overrepresentation.
We observed that the duplication level was high (over 90%) in most samples as expected for high sequencing-depth in RNA-seq; additionally, few samples were having a GC content over-representation (results not shown). Trimming was applied to remove Illumina primers and low-quality nucleotides. HTSEQ 41 intersection-option was used to assign fragments to genes. Data were normalized using cqn 42 , which corrects for GC content and gene-length. A non-parametric version of Combat methodology 43 was used after cqn to correct for librarypreparation effects.
miRNA-seq
The quality of the sequencing reads was checked with the Fastqc tool with good results (results not shown). Alignment of raw data was performed using Novoalign (http://novocraft.com/) on mouse miRNA sequences from mirBase. Quantification was performed using multiBamCov 44 and counts were found for 1,086 out of 1,908 miRNAs present in the database. Low count miRNAS were further filtered out with the CPM (counts per million) method in NOISeq R package 45 by setting a threshold of 1 for CPM. The final 
DNase-seq
DNase-seq reads were trimmed to 36bp and paired-end mapped to the mm10 reference genome using Bowtie2 47 with options: -v 2 -k 1 -m 1 --best -strata. DNase-seq peaks were called for each replicate using the HOMER findPeaks function. We employed a specific peak-calling strategy to capture several features of our DNaseI hypersensitive sites. Our strategy was to include both 'narrow' and 'broad' DHS peaks in our analysis. This captured a comprehensive set of sites with a wide DHS dynamic range. Initially, we used HOMER to determine narrow DHS peaks using a default size parameter (120-150bp) with a minimum peak distance of 50bp between DHS and an FDR of 1%. We then included a second round of peak calling, restricting to a peak size of 500bp with a minimum peak distance of 50bp
between DHS peaks and an FDR of 1%. We then merged the two peak sets for each replicate. We required a minimum 1bp overlap of peaks across all three biological replicates for each time-point respectively and generated a consensus DHS peak list across all timepoints.
The consensus DHS (53,624) were filtered for chrM peaks, partial chromosomes, and mouse ENCODE blacklist regions. Counts representing the chromatin accessibility were estimated for each consensus DHS using the Bedtools coverageBed function. Additionally, no DHS were considered with less than 10 reads (~1 RPM) in all time-points, resulting in a final dataset with 52,788 consensus DHSs. Data were normalized by a combination of RPKM and TMM and batch effects were removed by the ARSyN method 48 .
RRBS
Initial quality assessment was based on data passing the Illumina Chastity filter. The second quality assessment was based on the reads using the Fastqc quality control tool version 0.10.0. Reads were adaptor-and quality-trimmed using Trim-Galore Software v0.3.4
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) in RRBS paired-end mode, in order to decrease methylation call errors arising from poor quality data. Mapping to the reference genome (GRCm38, mm10) was performed using Bismark v0.10.1 49 and Bowtie2 47 . The quality of the mapping was inspected using HTSEQ-qa 41 . SAM files were used as input in Bismark to obtain methylation calls. Paired-end mode with no overlap mode was specified. The first four bases from each read were avoided to eliminate M-bias, i.e.
deviation from the horizontal line in the mean CpG methylation level for each read position.
BedGraph and *.cov files were further considered and analyzed with the BiSeq package 50 .
Coverage was inspected before proceeding to smooth the methylation levels (between 0 and 1) per CpG site. Briefly, we firstly defined "frequently covered CpG sites" as those sites that are covered in at least 2/3 of the samples. The frequently covered CpG sites were considered only to define the cluster boundaries and we defined CpG clusters using a maximum distance of 100 bp and at least 20 CpGs. This selection resulted in 1,116,417
CpG sites within CpG clusters, with no threshold on coverage. The extra coverage of unusually high covered sites (95% quantile of the coverage) was eliminated to remove potential biases during the smoothing step introduced by CpGs with exceptional high coverage. Then, the methylation levels were smoothed with a bandwidth of 80 bp as Gene expression measurements for each single-cell library were merged and normalized into a single data matrix using Cuffnorm. Genes with zero counts in more than 80% of the samples were removed resulting in a data matrix with 9,075 genes.
ATAC-seq
Single-cell libraries were mapped with Bowtie 47 to the mm10 reference genome using the following parameters (bowtie -S -p 2 --trim3 10 -X 2000). Duplicate fragments were removed using Picard (http://picard.sourceforge.net). We considered single-cell libraries that recovered > 5k fragments after mapping and duplication removal. Bulk ATAC-seq replicates were mapped to the mm10 reference genome using the following parameters (bowtie2 -S -p were not randomly distributed, but associated to particular samples, we believed that a misalignment of chromatograms played a role. We improved the alignment between samples to rescue some of the missing values.
b) RNA-seq data was used as database source protein identification. The rationale is that the mRNAs of expressed proteins should be found within the RNA-seq detected genes. Reducing the size of the protein database to proteins detected by RNA-Seq will reduce the number of false hits and lead therefore to more specific data on the pre-B cell proteome. Since proteomic data exhibit a lower coverage of the proteins abundant in a cell, a substantial data loss is not expected. 
Metabolomics
For the GC platform, a 13C labelled yeast extract was added as internal standard. A Quality
Control (QC) sample was measured every 6 samples. Of each of the compounds measured on the GC platform, the labelled compound that lead to the smallest standard error in the QC samples for that compound, was selected as internal standard. Because the amount of sample was almost completely used for the two analytical platforms no replicate analyses were possible. This meant that the internal standard selection could not be validated using replicate samples as is common practice. For the targeted LCMS method, the optimal internal standards for each metabolite were chosen during optimization and validation of the method. The limited within batch drift effects were corrected using the batch correction approach developed by van der Kloet et al 53 .
Four biological batches (batches 9 through 12) were provided to the metabolomics platforms, which were (physically) different from the batches used for mRNA-seq, miRNAseq and proteomics. Visual inspection showed that samples of batch 11 and 12 were not completely dry. Analysis of some key metabolites showed batch 12 levels to be outlying the general trend in batches 9, 10 and 11. Therefore, it was decided to exclude batch 12 from further analysis.
Both analytical platforms show some overlap in the metabolites that were measured.
On GCMS 22 metabolites were uniquely quantified and 18 metabolites were quantified uniquely on LCMS, while 18 metabolites were quantified both on GCMS and LCMS, making a total of 58 metabolites. Although the intensity levels of the GCMS and LCMS were rather different a high correlation between the two platforms for most overlapping metabolites was observed. Metabolite levels were log scaled and levels were mean-centered over the three batches 9, 10 and 11. For the metabolites that were measured both on GCMS and LCMS weighted averages were calculated where the weight was defined as the inverse of the relative standard deviation (RSD) of that metabolite on its specific platform obtained from repeated analyses of pooled samples.
Data Records Raw data
STATegra multiomics data have been deposited in different public repositories dedicated to the different data types. Table 1 shows a list of the current hosting of raw data files.
Moreover, pre-processed data arranged as a data-matrix per omics data-type have also made available at Lifebit (https://lifebit.ai/) site. Figure 5 . The overlay of own experimental data on top of such networks would help interpretation of results as well as validate database predictions. 
Technical validation Validation of time course replicability
As a quality control of batch replicability, real time RT-PCR was used to check the impact of Ikaros in gene expression upon induction and reproducibility across time course experiments. RNA from all samples was extracted using RNAbee (AMS Biotechnology (Europe) Ltd) and treated with Turbo DNAse (Life technologies). Bioanalyser technology was used to check the RNA integrity and samples were quantified using a Nanodrop. Changes in the expression of few previously identified Ikaros-responsive genes were analysed ( Figure 6 ). As expected, early down-regulation of Igll1 and Myc, late down-regulation of Slc7a5, Hk2
and Ldha, and up-regulation of Foxo1 and Lig4 were consistently observed in the three independently collected time course replicates. Either frozen pellets or RNA samples from the time course experiments and 0h time point collections were sent to the different experimental labs to perform the library preparation for the sequencing. Validation of dataset co-variation structure.
To understand wether the different omics measurements captured the dynamics of B-cell differentiation and/or had a similar co-variation structure, we ran Principal Component
Analysis for all datasets ( Figure 7 ). In general, the different multiomics datasets show PCA plots that recapitulate the time progression of our inducible system. A well spread temporal progression on the first PC was observed for mRNA-seq, miRNA-seq and scRNA-seq data, 
